✦ LIBER ✦

Does Timing of Cytoreductive Nephrectomy Impact Patient Survival With Metastatic Renal Cell Carcinoma in the Tyrosine Kinase Inhibitor Era? A Multi-institutional Study

✍ Scribed by Stroup, Sean P.; Raheem, Omer A.; Palazzi, Kerrin L.; Liss, Michael A.; Mehrazin, Reza; Kopp, Ryan P.; Patel, Nishant; Cohen, Seth A.; Park, Samuel K.; Patterson, Anthony L.; Kane, Christopher J.; Millard, Frederick; Derweesh, Ithaar H.

Book ID: 119965367
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 292 KB
Volume: 81
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2012.10.054

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1776 DOES TIMING OF CYTOREDUCTIVE NEPHRE

1776 DOES TIMING OF CYTOREDUCTIVE NEPHRECTOMY IMPACT PATIENT SURVIVAL WITH METASTATIC RENAL CELL CARCINOMA IN THE TYROSINE KINASE INHIBITOR ERA?

✍ Stroup, Sean; Raheem, Omer; Kopp, Ryan; Palazzi-Churas, Kerrin; Mehrazin, Reza; 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 87 KB

Improved survival in patients with metas

Improved survival in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the era of targeted therapy

✍ Sakai, Iori; Miyake, Hideaki; Hinata, Nobuyuki; Fujisawa, Masato 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 263 KB

1916 IMPROVED SURVIVAL IN PATIENTS WITH

1916 IMPROVED SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE ERA OF TARGETED THERAPY

✍ Hinata, Nobuyuki; Miyake, Hideaki; Fujisawa, Masato 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 50 KB

Are Tyrosine Kinase Inhibitors Still Act

Are Tyrosine Kinase Inhibitors Still Active in Patients With Metastatic Renal Cell Carcinoma Previously Treated With a Tyrosine Kinase Inhibitor and Everolimus? Experience of 36 Patients Treated in France in the RECORD-1 Trial

✍ Blesius, Aurore; Beuselinck, Benoit; Chevreau, Christine; Ravaud, Alain; Rolland 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 303 KB

Prolonged use of the tyrosine kinase inh

Prolonged use of the tyrosine kinase inhibitor in a peritoneal dialysis patient with metastatic renal cell carcinoma: possible beneficial effects on peritoneal membrane and peritonitis rates

✍ Shruti N. Tapiawala; Joanne M. Bargman; Dimitrios G. Oreopoulos; Martin Simons 📂 Article 📅 2009 🏛 Springer Netherlands 🌐 English ⚖ 137 KB

A phase 1b clinical trial of the multi-t

A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)

✍ Molina, Ana M.; Hutson, Thomas E.; Larkin, James; Gold, Anne M.; Wood, Karen; Ca 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 395 KB